CD57 Antikörper (PE,Cy7)
Kurzübersicht für CD57 Antikörper (PE,Cy7) (ABIN7566608)
Target
Alle CD57 (B3GAT1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- PE/Cyanine7 Anti-Human CD57 Antibody[HI57a]
-
Isotyp
- IgM, kappa
-
-
-
-
Applikationshinweise
-
Each lot of this antibody is quality control tested by flow cytometric analysis. Applications vary, the appropriate dilutions must be determined for individual use.
FCM: 5 µL/test -
Kommentare
-
Matching Isotype Control: (ABIN7469747)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
-
Haltbarkeit
- 12 months
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
Andere Bezeichnung
- CD57
-
Hintergrund
- Galactosylgalactosylxylosylprotein3-beta-glucuronosyltransferase1,B3GAT1,GlcAT-P,GlcUAT-P,GLCATP,CD57, also known as TB01, NK-1, and Leu-7 is a 100-115 kD oligosaccharide antigenic determinant expressed on a variety of proteins, lipids, and chondroitin sulfate proteoglycans. CD57 is expressed on a subset of peripheral blood lymphocytes, including NK cells and CD8+ T cells, and is also expressed on neural cells and striated muscle. CD57 is not expressed on red blood cells, granulocytes, monocytes, or platelets. While the function of CD57 is unknown, binding to L-selectin, P-selectin, and a fragment of laminin suggests that CD57 may be involved in cell-matrix interactions. CD57 is increased in some disease states associated with CD4/CD8 imbalances (AIDS, autoimmune disease, viral infections, and allograft transplants).
-
Gen-ID
- 27087
-
UniProt
- Q9P2W7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-